The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease.

MLA

Das, Shreyasee, et al. “The Use of Synaptic Biomarkers in Cerebrospinal Fluid to Differentiate Behavioral Variant of Frontotemporal Dementia from Primary Psychiatric Disorders and Alzheimer’s Disease.” Alzheimer’s Research & Therapy, vol. 16, no. 1, Feb. 2024, p. 34. EBSCOhost, https://doi.org/10.1186/s13195-024-01409-8.

APA

Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024). The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease. Alzheimer’s Research & Therapy, 16(1), 34. https://doi.org/10.1186/s13195-024-01409-8

Chicago

Das, Shreyasee, Marie-Paule E van Engelen, Julie Goossens, Dirk Jacobs, Bram Bongers, Jay L P Fieldhouse, Yolande A L Pijnenburg, Charlotte E Teunissen, Eugeen Vanmechelen, and Inge M W Verberk. 2024. “The Use of Synaptic Biomarkers in Cerebrospinal Fluid to Differentiate Behavioral Variant of Frontotemporal Dementia from Primary Psychiatric Disorders and Alzheimer’s Disease.” Alzheimer’s Research & Therapy 16 (1): 34. doi:10.1186/s13195-024-01409-8.